Price T Rowe Associates Inc Syros Pharmaceuticals, Inc. Transaction History

Price T Rowe Associates Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.69 - $1.21 $27 - $48	40 Added 0.05%	80,924 $78,000
Q1 2022 May 16, 2022	SELL	$1.02 - $3.8 $20,808 - $77,520	-20,400 Reduced 20.14%	80,884 $96,000
Q4 2021 Feb 14, 2022	BUY	$3.26 - $4.66 $170,172 - $243,252	52,200 Added 106.35%	101,284 $330,000
Q3 2021 Nov 15, 2021	BUY	$4.08 - $5.66 $200,262 - $277,815	49,084 New	49,084 $219,000
Q1 2021 May 17, 2021	SELL	$7.19 - $14.95 $342,193 - $711,515	-47,593 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$6.66 - $14.66 $316,969 - $697,713	47,593 New	47,593 $516,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.